We use cookies to improve your experience on our site and to analyze traffic. By clicking "Accept", you consent to our use of cookies. Learn more.

Nova In Silico will be at ACoP 2026·Meet the team and see our programDetails here

About

News & conferences

Company announcements, scientific milestones, and the conferences where our team presents Jinkō.

ConferenceNov 17–19, 2026Boston, Massachusetts

Model-Informed Drug Development Summit, second edition

Meet Jim Bosley, Cristhyne Leon, and Julie Pitrat at the second Model-Informed Drug Development Summit.

ConferenceNov 16–18, 2026Berlin, Germany

ESMO AI & Digital Oncology Congress 2026

Meet Simon, Frédéric, and Yishu (Hélio) Wang at ESMO AI in Berlin.

ConferenceOct 23–27, 2026Madrid, Spain

ESMO Congress 2026

Meet Greg and Claudio at ESMO 2026.

ConferenceOct 12–15, 2026National Harbor, Maryland

ACoP 2026

Meet Nova at ACoP 2026 for one tutorial, one talk, and eight posters on QSP, Digital Twins, and agent-assisted modeling.

Press releaseSep 23, 2026Lyon, France

Pelacarsen, Lp(a)HORIZON, 8,323 patients, and how a mechanistic model earns credibility

Nova In Silico announced the results of its prospective simulation of the Lp(a)HORIZON Phase III trial of pelacarsen, deposited on Zenodo under restricted access on June 2, 2026, before the topline results were known.

Press releaseNov 14, 2025Lyon, France

Nova In Silico prospectively predicts LDL-C outcomes of Merck's Phase 3 CORALreef Lipids trial using an In Silico clinical trial

Nova's predeclared simulation quantitatively aligned with the LDL-C reductions later reported from Merck's Phase 3 CORALreef Lipids trial.

Press releaseApril 2025Lyon, France and Tokyo, Japan

Nova collaborates with Fujitsu to transform clinical trials through AI-powered simulations

Nova and Fujitsu are combining biosimulation, AI, and real-world health data to improve clinical trial design and develop Japan-specific virtual populations.